Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities

Acute myocardial infarction (AMI) and the heart failure that often follows, are major causes of death and disability worldwide. As such, new therapies are required to limit myocardial infarct (MI) size, prevent adverse left ventricular (LV) remodeling, and reduce the onset of heart failure following...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacol Ther
Asıl Yazarlar: Ong, Sang-Bing, Hernández-Reséndiz, Sauri, Crespo-Avilan, Gustavo E., Mukhametshina, Regina T., Kwek, Xiu-Yi, Cabrera-Fuentes, Hector A., Hausenloy, Derek J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Pergamon Press 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5981007/
https://ncbi.nlm.nih.gov/pubmed/29330085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2018.01.001
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller